share_log

Insiders Sold CN¥11m Of Peijia Medical Stock Possibly Sending Warning Sign

Insiders Sold CN¥11m Of Peijia Medical Stock Possibly Sending Warning Sign

业内人士出售了1100万元人民币的培佳医疗股票,可能发出警告信号
Simply Wall St ·  2023/11/20 17:51

Despite a 14% gain in Peijia Medical Limited's (HKG:9996) stock price this week, shareholders shouldn't let up. Although prices were relatively low, insiders chose to sell CN¥11m worth of stock in the past 12 months. This could be a sign of impending weakness.

尽管本周培佳医疗有限公司(HKG: 9996)的股价上涨了14%,但股东们不应放松。尽管价格相对较低,但在过去的12个月中,内部人士选择出售价值1100万元人民币的股票。这可能是即将出现疲软的迹象。

While we would never suggest that investors should base their decisions solely on what the directors of a company have been doing, logic dictates you should pay some attention to whether insiders are buying or selling shares.

虽然我们绝不会建议投资者仅根据公司董事的所作所为做出决定,但逻辑要求你应该注意内部人士是在买入还是卖出股票。

See our latest analysis for Peijia Medical

查看我们对培佳医疗的最新分析

Peijia Medical Insider Transactions Over The Last Year

培佳医疗过去一年的内幕交易

In the last twelve months, the biggest single sale by an insider was when the Executive Director & Company Secretary, Hong Ye, sold HK$3.1m worth of shares at a price of HK$11.09 per share. While we don't usually like to see insider selling, it's more concerning if the sales take place at a lower price. It's of some comfort that this sale was conducted at a price well above the current share price, which is HK$7.95. So it may not tell us anything about how insiders feel about the current share price. Hong Ye was the only individual insider to sell over the last year.

在过去的十二个月中,内部人士最大的一次出售是执行董事兼公司秘书Hong Ye以每股11.09港元的价格出售了价值310万港元的股票。虽然我们通常不喜欢看到内幕抛售,但更令人担忧的是销售是否以较低的价格进行。令人欣慰的是,此次出售的价格远高于目前的股价,即7.95港元。因此,它可能无法告诉我们内部人士对当前股价的看法。Hong Ye是去年唯一一位卖出的个人内部人士。

Hong Ye divested 1.04m shares over the last 12 months at an average price of CN¥10.71. You can see a visual depiction of insider transactions (by companies and individuals) over the last 12 months, below. If you click on the chart, you can see all the individual transactions, including the share price, individual, and the date!

在过去的12个月中,宏业剥离了104万股股票,平均价格为10.71元人民币。你可以在下面看到过去 12 个月内幕交易(由公司和个人进行的)的直观描述。如果你点击图表,你可以看到所有的个人交易,包括股价、个人和日期!

insider-trading-volume
SEHK:9996 Insider Trading Volume November 20th 2023
香港交易所:9996 内幕交易量 2023 年 11 月 20 日

I will like Peijia Medical better if I see some big insider buys. While we wait, check out this free list of growing companies with considerable, recent, insider buying.

如果我看到一些大笔的内幕买入,我会更喜欢培佳医疗。在我们等待的同时,请查看这份免费名单,列出了最近有大量内幕买入的成长型公司。

Does Peijia Medical Boast High Insider Ownership?

培佳医疗是否拥有很高的内幕所有权?

For a common shareholder, it is worth checking how many shares are held by company insiders. We usually like to see fairly high levels of insider ownership. Peijia Medical insiders own about HK$164m worth of shares. That equates to 3.1% of the company. We've certainly seen higher levels of insider ownership elsewhere, but these holdings are enough to suggest alignment between insiders and the other shareholders.

对于普通股股东来说,值得检查一下公司内部人士持有多少股票。我们通常希望看到相当高的内部所有权水平。培佳医疗内部人士拥有价值约1.64亿港元的股票。这相当于该公司的3.1%。当然,我们在其他地方看到了更高的内幕所有权水平,但这些持股足以表明内部人士与其他股东保持一致。

So What Does This Data Suggest About Peijia Medical Insiders?

那么,这些数据对培佳医学内幕人士有何启示呢?

It doesn't really mean much that no insider has traded Peijia Medical shares in the last quarter. While we feel good about high insider ownership of Peijia Medical, we can't say the same about the selling of shares. In addition to knowing about insider transactions going on, it's beneficial to identify the risks facing Peijia Medical. To assist with this, we've discovered 1 warning sign that you should run your eye over to get a better picture of Peijia Medical.

上个季度没有内部人士交易过培佳医疗的股票,这并不意味着什么。尽管我们对培佳医疗的高内幕所有权感到满意,但对于出售股票,我们不能说同样的话。除了了解正在进行的内幕交易外,识别培佳医疗面临的风险也是有益的。为了帮助解决这个问题,我们发现了 1 个警告信号,你应该仔细观察才能更好地了解 Peijia Medical。

Of course Peijia Medical may not be the best stock to buy. So you may wish to see this free collection of high quality companies.

当然,培佳医疗可能不是最值得买入的股票。因此,您可能希望看到这些免费的高质量公司集。

For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests.

就本文而言,内部人士是指向相关监管机构报告其交易的个人。我们目前只考虑公开市场交易和私下处置的直接利益,不包括衍生品交易或间接权益。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

对这篇文章有反馈吗?对内容感到担忧?直接联系我们。 或者,给编辑团队 (at) simplywallst.com 发送电子邮件。
Simply Wall St的这篇文章本质上是笼统的。我们仅使用公正的方法根据历史数据和分析师的预测提供评论,我们的文章无意作为财务建议。它不构成买入或卖出任何股票的建议,也没有考虑到您的目标或财务状况。我们的目标是为您提供由基本数据驱动的长期重点分析。请注意,我们的分析可能不考虑最新的价格敏感型公司公告或定性材料。简而言之,华尔街没有持有任何上述股票的头寸。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发